F 0637
Assess the resident when there is a significant change in condition
Level of Harm - Minimal harm
or potential for actual harm
Based on clinical record review, staff interview, and Centers for Medicare and Medicaid Services
publication, it was determined that the facility failed to complete a Significant Change Minimum Data Set
after a significant change was identified for one of two residents reviewed for hospice services (Resident
45).
Residents Affected - Few
Findings include:
Review of Centers for Medicare & Medicaid Services' Long-Term Care Facility Resident Assessment
Instrument 3.0 User's Manual, version 1.19.1 (instructions on when and how to complete the Minimum Data
Set), revealed it stated, An [Significant Change in Status Assessment; a.k.a. Significant Change Minimum
Data Set] is required to be performed when a terminally ill resident enrolls in a hospice program
(Medicare-certified or State-licensed hospice provider) or changes hospice providers and remains a
resident at the nursing home. The [Assessment Reference Date] must be within 14 days from the effective
date of the hospice election .
Review of Resident 45's clinical record revealed diagnoses that included Alzheimer's disease (progressive,
irreversible degenerative disease of the brain that results in decreased contact with reality and decreased
ability to perform activities of daily living) and hypertension (elevated/high blood pressure).
Review of Resident 45's clinical record revealed that on July 22, 2024, Resident 45 entered into hospice
services.
Review of the Minimum Data Set (MDS) assessment history for Resident 45 revealed that a Significant
Change MDS was not completed until September 13, 2024; 53 days after Resident 45 had entered into
hospice services.
During a staff interview on March 13, 2025, at approximately 11:10 AM, Nursing Home Administrator (NHA)
confirmed that the Registered Nurse Assessment Coordinator identified that Resident 45 did not have a
Significant Change MDS completed within 14 days, and subsequently completed the Significant Change
MDS with an assessment reference date of September 13, 2024. During the interview, the NHA confirmed
that it was the facility's expectation that Significant Change MDS assessment are completed within 14 days
after the facility identifies significant change in resident condition.
28 Pa code 211.12(d)(1)(3)(5) Nursing services
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 3
Event ID:
395923
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395923
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/13/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Chapel Pointe at Carlisle
770 S. Hanover Street
Carlisle, PA 17013
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0641
Ensure each resident receives an accurate assessment.
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
clinical record review and staff interviews, it was determined that the facility failed to ensure that the
resident assessment accurately reflected the resident's status for two of 17 residents reviewed (Residents 7
and 20).
Residents Affected - Few
Findings Include:
Review of Resident 7's clinical record revealed diagnoses that included congestive heart failure (CHF- a
chronic condition in which the heart doesn't pump blood as well as it should) and Type 2 Diabetes Mellitus
(when the body cannot use insulin correctly and sugar builds up in the blood).
Review of Resident 7's Quarterly MDS (Minimum Data Set - an assessment tool to review all care areas
specific to the resident such as a resident's physical, mental, or psychosocial needs) dated November 1,
2024, revealed that in Section N, opioid medication (a class of drug used to reduce moderate to severe
pain) was not checked as being received by the resident during the last seven days.
Review of Resident 7's medication administration record (MAR), dated October 2024 and November 2024,
revealed that Resident 7 received Tramadol (an opioid medication) every day.
On March 13, 2025, at 11:47 AM, the Nursing Home Administrator (NHA) confirmed that Resident 7
received the Tramadol and that the opioid medication should have been coded on the MDS.
Review of Resident 20's clinical record revealed diagnoses that included Parkinson's Disease (a disorder of
the central nervous system that affects movement, often including tremors) and Type 2 Diabetes Mellitus.
Further review of Resident 20's clinical record revealed that he was admitted to the hospital on [DATE], and
readmitted to the facility on [DATE].
Review of Resident 20's hospital Discharge summary, dated [DATE], revealed that he was diagnosed with a
UTI (urinary tract infection) during his hospital admission.
Review of Resident 20's physician note, dated January 3, 2025, revealed that Resident 20 was diagnosed
with a UTI during his hospitalization.
Review of Resident 20's MAR, dated January 2025, revealed that Resident 20 received Levaquin
(antibiotic) on January 4-7, for treatment of his UTI.
Review of Resident 20's significant change MDS, dated [DATE], revealed in section I, it was not coded that
Resident 20 had a UTI in the past 30 days.
Further review of the MDS revealed in Section N, it was not coded that Resident 20 received an antibiotic in
the past seven days.
On March 13, 2025, at 10:32 AM, the NHA stated that the UTI was missed being coded on the MDS and
one day of antibiotic should have been coded during the seven day lookback period.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395923
If continuation sheet
Page 2 of 3
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395923
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
03/13/2025
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Chapel Pointe at Carlisle
770 S. Hanover Street
Carlisle, PA 17013
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0641
28 Pa. Code 211.12(d)(1)(3)(5) Nursing services
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395923
If continuation sheet
Page 3 of 3